{"id":6802,"date":"2024-05-23T08:15:00","date_gmt":"2024-05-23T08:15:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/"},"modified":"2024-05-23T08:15:00","modified_gmt":"2024-05-23T08:15:00","slug":"realheart-publicerar-arsredovisning-for-2023","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/","title":{"rendered":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023"},"content":{"rendered":"<div class=\"mfn-body\">\n<p>Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2023.<br \/>\u00c5rsredovisningen inklusive revisionsber\u00e4ttelse \u00e5terfinns p\u00e5\u00a0<a href=\"http:\/\/www.realheart.se\/\" rel=\"noopener\" target=\"_blank\">www.realheart.se<\/a>\u00a0samt som bilaga i detta pressmeddelande.\u00a0<\/p>\n<p>Senare kommer \u00e4ven en engelsk version\/\u00f6vers\u00e4ttning av \u00e5rsredovisningen att publiceras.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-ddde9c982a0b\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information, kontakta:<\/strong><br \/>Ina Laura Perkins, VD<br \/>Tel: +46 (0) 70 406 49 21<br \/>E-post: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"noopener\" target=\"_blank\">inalaura.perkins@realheart.se<\/a><br \/>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, <a href=\"http:\/\/www.skmg.se\" rel=\"noopener\" target=\"_blank\">www.skmg.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-0285b54ad9f5\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><br \/>Scandinavian Real Heart \u00e4r verksamt inom medicinteknik. Bolaget bedriver forskning och utveckling inom observationer av hj\u00e4rtats fysiologi. Utvecklingen av bolagets produkt, ett komplett artificiellt hj\u00e4rta (TAH), sker i samarbete med hj\u00e4rtkirurger, forskare och ingenj\u00f6rer. Fokus ligger mot att utveckla patenterade l\u00f6sningar som kan imitera det naturliga m\u00e4nskliga hj\u00e4rtats blodcirkulation. L\u00f6sningarna avses anv\u00e4ndas av patienter som diagnostiserats med hj\u00e4rtsvikt.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/4ff70cd5-abd8-41a5-a17f-c47b81fd7d97\/arsredovisning-realheart-2023-sve-240523-inkl-rev-ber-lu.pdf\" rel=\"noopener\" target=\"_blank\">\u00c5RSREDOVISNING Realheart 2023 SVE 240523 Inkl Rev Ber LU<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/4ff70cd5-abd8-41a5-a17f-c47b81fd7d97\/arsredovisning-realheart-2023-sve-240523-inkl-rev-ber-lu.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/4ff70cd5-abd8-41a5-a17f-c47b81fd7d97\/arsredovisning-realheart-2023-sve-240523-inkl-rev-ber-lu.pdf?type=jpg\"><\/span>\u00c5RSREDOVISNING Realheart 2023 SVE 240523 Inkl Rev Ber LU<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2023.\u00c5rsredovisningen inklusive revisionsber\u00e4ttelse \u00e5terfinns p\u00e5\u00a0www.realheart.se\u00a0samt som bilaga i detta pressmeddelande.\u00a0 Senare kommer \u00e4ven en engelsk version\/\u00f6vers\u00e4ttning av \u00e5rsredovisningen att publiceras. F\u00f6r mer information, kontakta:Ina Laura Perkins, VDTel: +46 (0) 70 406 49 21E-post: inalaura.perkins@realheart.seCertified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se Om ossScandinavian Real Heart \u00e4r verksamt inom medicinteknik. Bolaget bedriver forskning&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6802","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-annual","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart publicerar \u00e5rsredovisning f\u00f6r 2023 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023 - Realheart\" \/>\n<meta property=\"og:description\" content=\"Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2023.\u00c5rsredovisningen inklusive revisionsber\u00e4ttelse \u00e5terfinns p\u00e5\u00a0www.realheart.se\u00a0samt som bilaga i detta pressmeddelande.\u00a0 Senare kommer \u00e4ven en engelsk version\/\u00f6vers\u00e4ttning av \u00e5rsredovisningen att publiceras. F\u00f6r mer information, kontakta:Ina Laura Perkins, VDTel: +46 (0) 70 406 49 21E-post: inalaura.perkins@realheart.seCertified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se Om ossScandinavian Real Heart \u00e4r verksamt inom medicinteknik. Bolaget bedriver forskning...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2023\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2023\\\/\",\"name\":\"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2024-05-23T08:15:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2023\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-publicerar-arsredovisning-for-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023 - Realheart","og_description":"Idag publicerar Realheart \u00e5rsredovisningen f\u00f6r 2023.\u00c5rsredovisningen inklusive revisionsber\u00e4ttelse \u00e5terfinns p\u00e5\u00a0www.realheart.se\u00a0samt som bilaga i detta pressmeddelande.\u00a0 Senare kommer \u00e4ven en engelsk version\/\u00f6vers\u00e4ttning av \u00e5rsredovisningen att publiceras. F\u00f6r mer information, kontakta:Ina Laura Perkins, VDTel: +46 (0) 70 406 49 21E-post: inalaura.perkins@realheart.seCertified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se Om ossScandinavian Real Heart \u00e4r verksamt inom medicinteknik. Bolaget bedriver forskning...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/","name":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2024-05-23T08:15:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-publicerar-arsredovisning-for-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart publicerar \u00e5rsredovisning f\u00f6r 2023"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}